Literature DB >> 24717031

Potential role of high-mobility group box 1 protein in the pathogenesis of influenza H5N1 virus infection.

X Q Hou, J L Qin, X X Zheng, L Wang, S T Yang, Y W Gao, X Z H Xia.   

Abstract

During influenza A virus (IAV) (H5N1) infection, the levels of inflammatory cytokines are markedly elevated in the lungs of infected hosts. One of them, high-mobility group box 1 protein (HMGB1) functions in regulation of cellular transcription and activation of proinflammatory responses, but little is known about its role in viral infection. In this study, we attempted to address this question. Using an IAV (H5N1) - mouse model, lung tissues were analyzed for virus titer, expression of HMGB1 and other inflammatory cytokines and histopathological changes. Moreover, the effect of administration of HMGB1-specific antibody to the infected mice on these parameters was investigated. The results showed that the HMGB1 expression was induced on days 3-7 post infection (p.i.) and primarily localized to epithelial cells of alveoli and bronchioles. The HMGB1-specific antibody reduced the levels of inflammatory cytokines and chemokines and the survival rate, but did not influence the virus titer. Summing up, these data suggest that HMGB1 contributes to the pathogenesis of IAV (H5N1) infection in mice by inducing extensive inflammatory responses and severe pneumonia.

Entities:  

Keywords:  HMGB1; influenza A virus (H5N1); pathogenesis.

Mesh:

Substances:

Year:  2014        PMID: 24717031     DOI: 10.4149/av_2014_01_69

Source DB:  PubMed          Journal:  Acta Virol        ISSN: 0001-723X            Impact factor:   1.162


  14 in total

1.  High-mobility group box1 as an amplifier of immune response and target for treatment in Aspergillus fumigatus keratitis.

Authors:  Meng-Qi Wu; Cui Li; Li-Na Zhang; Jing Lin; Kun He; Ya-Wen Niu; Cheng-Ye Che; Nan Jiang; Jia-Qian Jiang; Gui-Qiu Zhao
Journal:  Int J Ophthalmol       Date:  2020-05-18       Impact factor: 1.779

Review 2.  The Role of HMGB1, a Nuclear Damage-Associated Molecular Pattern Molecule, in the Pathogenesis of Lung Diseases.

Authors:  Mao Wang; Alex Gauthier; LeeAnne Daley; Katelyn Dial; Jiaqi Wu; Joanna Woo; Mosi Lin; Charles Ashby; Lin L Mantell
Journal:  Antioxid Redox Signal       Date:  2019-07-11       Impact factor: 8.401

3.  Respiratory Syncytial Virus Infection Triggers Epithelial HMGB1 Release as a Damage-Associated Molecular Pattern Promoting a Monocytic Inflammatory Response.

Authors:  Yashoda M Hosakote; Allan R Brasier; Antonella Casola; Roberto P Garofalo; Alexander Kurosky
Journal:  J Virol       Date:  2016-10-14       Impact factor: 5.103

4.  Anti-high mobility group box-1 monoclonal antibody treatment provides protection against influenza A virus (H1N1)-induced pneumonia in mice.

Authors:  Nobuyuki Nosaka; Masato Yashiro; Mutsuko Yamada; Yosuke Fujii; Hirokazu Tsukahara; Keyue Liu; Masahiro Nishibori; Akihiro Matsukawa; Tsuneo Morishima
Journal:  Crit Care       Date:  2015-06-11       Impact factor: 9.097

5.  RAGE deficiency predisposes mice to virus-induced paucigranulocytic asthma.

Authors:  Jaisy Arikkatt; Md Ashik Ullah; Kirsty Renfree Short; Vivan Zhang; Wan Jun Gan; Zhixuan Loh; Rhiannon B Werder; Jennifer Simpson; Peter D Sly; Stuart B Mazzone; Kirsten M Spann; Manuel Ar Ferreira; John W Upham; Maria B Sukkar; Simon Phipps
Journal:  Elife       Date:  2017-01-18       Impact factor: 8.140

6.  Porcine epidemic diarrhea virus nucleoprotein contributes to HMGB1 transcription and release by interacting with C/EBP-β.

Authors:  Chang-Chao Huan; Hua-Xia Wang; Xiang-Xiang Sheng; Rui Wang; Xin Wang; Ying Liao; Qin-Fang Liu; Guang-Zhi Tong; Chan Ding; Hong-Jie Fan; Jia-Qiang Wu; Xiang Mao
Journal:  Oncotarget       Date:  2016-11-15

Review 7.  Extracellular HMGB1: a therapeutic target in severe pulmonary inflammation including COVID-19?

Authors:  Ulf Andersson; William Ottestad; Kevin J Tracey
Journal:  Mol Med       Date:  2020-05-07       Impact factor: 6.354

Review 8.  Relevant mediators involved in and therapies targeting the inflammatory response induced by activation of the NLRP3 inflammasome in ischemic stroke.

Authors:  Qingxue Xu; Bo Zhao; Yingze Ye; Yina Li; Yonggang Zhang; Xiaoxing Xiong; Lijuan Gu
Journal:  J Neuroinflammation       Date:  2021-05-31       Impact factor: 8.322

Review 9.  Severe COVID-19: NLRP3 Inflammasome Dysregulated.

Authors:  Daan F van den Berg; Anje A Te Velde
Journal:  Front Immunol       Date:  2020-06-26       Impact factor: 7.561

Review 10.  Role of DAMPs in respiratory virus-induced acute respiratory distress syndrome-with a preliminary reference to SARS-CoV-2 pneumonia.

Authors:  Walter Gottlieb Land
Journal:  Genes Immun       Date:  2021-06-17       Impact factor: 2.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.